Torthaí cuardaigh - Dongwei Kang
- 1 - 20 toradh as 20 á dtaispeáint
-
1
Recent developments in the medicinal chemistry of single boron atom-containing compounds de réir Shu Song, Ping Gao, Lin Sun, Dongwei Kang, Jacob Kongsted, Vasanthanathan Poongavanam, Peng Zhan, Xinyong Liu
Foilsithe / Cruthaithe 2021Revisão -
2
Newly Emerging Strategies in Antiviral Drug Discovery: Dedicated to Prof. Dr. Erik De Clercq on Occasion of His 80th Anniversary de réir Shujing Xu, Dang Ding, Xujie Zhang, Lin Sun, Dongwei Kang, Boshi Huang, Xinyong Liu, Peng Zhan
Foilsithe / Cruthaithe 2022Revisão -
3
Design, synthesis and biological evaluation of tacrine-1,2,3-triazole derivatives as potent cholinesterase inhibitors de réir Gaochan Wu, Yun Gao, Dongwei Kang, Boshi Huang, Zhipeng Huo, Huiqing Liu, Vasanthanathan Poongavanam, Peng Zhan, Xinyong Liu
Foilsithe / Cruthaithe 2017Artigo -
4
Structural basis for potent and broad inhibition of HIV-1 RT by thiophene[3,2-d]pyrimidine non-nucleoside inhibitors de réir Yang Yang, Dongwei Kang, Laura A. Nguyen, Z.B. Smithline, Christophe Pannecouque, Peng Zhan, Xinyong Liu, Thomas A. Steitz
Foilsithe / Cruthaithe 2018Artigo -
5
Structure-Based Bioisosterism Yields HIV-1 NNRTIs with Improved Drug-Resistance Profiles and Favorable Pharmacokinetic Properties de réir Dongwei Kang, Da Feng, Yanying Sun, Zengjun Fang, Fenju Wei, Erik De Clercq, Christophe Pannecouque, Xinyong Liu, Peng Zhan
Foilsithe / Cruthaithe 2020Artigo -
6
Medicinal chemistry strategies for discovering antivirals effective against drug-resistant viruses de réir Yue Ma, Estrella Frutos-Beltrán, Dongwei Kang, Christophe Pannecouque, Erik De Clercq, Luis Menéndez‐Arias, Xinyong Liu, Peng Zhan
Foilsithe / Cruthaithe 2021Revisão -
7
Molecular design opportunities presented by solvent‐exposed regions of target proteins de réir Xiangyi Jiang, Ji Yu, Zhongxia Zhou, Jacob Kongsted, Yuning Song, Christophe Pannecouque, Erik De Clercq, Dongwei Kang, Vasanthanathan Poongavanam, Xinyong Liu, Peng Zhan
Foilsithe / Cruthaithe 2019Revisão -
8
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) membrane (M) protein inhibits type I and III interferon production by targeting RIG-I/MDA-5 signaling de réir Yi Zheng, Meng-Wei Zhuang, Lulu Han, Jing Zhang, Mei-Ling Nan, Peng Zhan, Dongwei Kang, Xinyong Liu, Chengjiang Gao, Pei‐Hui Wang
Foilsithe / Cruthaithe 2020Artigo -
9
Contemporary Medicinal Chemistry Strategies for the Discovery and Development of Novel HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors de réir Zhao Wang, Srinivasulu Cherukupalli, Minghui Xie, Wenbo Wang, Xiangyi Jiang, Ruifang Jia, Christophe Pannecouque, Erik De Clercq, Dongwei Kang, Peng Zhan, Xinyong Liu
Foilsithe / Cruthaithe 2022Artigo -
10
Exploring the hydrophobic channel of NNIBP leads to the discovery of novel piperidine-substituted thiophene[3,2-d]pyrimidine derivatives as potent HIV-1 NNRTIs de réir Dongwei Kang, Da Feng, Tiziana Ginex, Jinmi Zou, Fenju Wei, Tong Zhao, Boshi Huang, Yanying Sun, Samuel Desta, Erik De Clercq, Christophe Pannecouque, Peng Zhan, Xinyong Liu
Foilsithe / Cruthaithe 2019Artigo -
11
Discovery of phenylalanine derivatives as potent HIV-1 capsid inhibitors from click chemistry-based compound library de réir Gaochan Wu, Waleed A. Zalloum, Megan E. Meuser, Lanlan Jing, Dongwei Kang, Chin‐Ho Chen, Ye Tian, Fangfang Zhang, Simon Cocklin, Kuo‐Hsiung Lee, Xinyong Liu, Peng Zhan
Foilsithe / Cruthaithe 2018Artigo -
12
Development of enhanced HIV-1 non-nucleoside reverse transcriptase inhibitors with improved resistance and pharmacokinetic profiles de réir Zhao Wang, Shawn Rumrill, Dongwei Kang, Samuel Desta Guma, Da Feng, Erik De Clercq, Christophe Pannecouque, Chin‐Ho Chen, Eddy Arnold, Francesc X. Ruiz, Xinyong Liu, Peng Zhan
Foilsithe / Cruthaithe 2025Artigo -
13
Targeting the entrance channel of NNIBP: Discovery of diarylnicotinamide 1,4-disubstituted 1,2,3-triazoles as novel HIV-1 NNRTIs with high potency against wild-type and E138K mutan... de réir Ye Tian, Zhaoqiang Liu, Jinghan Liu, Boshi Huang, Dongwei Kang, H. Zhang, Erik De Clercq, Dirk Daelemans, Christophe Pannecouque, Kuo‐Hsiung Lee, Chin‐Ho Chen, Peng Zhan, Xinyong Liu
Foilsithe / Cruthaithe 2018Artigo -
14
Discovery and Characterization of Fluorine-Substituted Diarylpyrimidine Derivatives as Novel HIV-1 NNRTIs with Highly Improved Resistance Profiles and Low Activity for the hERG Ion... de réir Dongwei Kang, Francesc X. Ruiz, Da Feng, Alyssa Pilch, Tong Zhao, Fenju Wei, Zhao Wang, Yanying Sun, Zengjun Fang, Erik De Clercq, Christophe Pannecouque, Eddy Arnold, Xinyong Liu, Peng Zhan
Foilsithe / Cruthaithe 2020Artigo -
15
Structure-Based Optimization of N-Substituted Oseltamivir Derivatives as Potent Anti-Influenza A Virus Agents with Significantly Improved Potency against Oseltamivir-Resistant N1-H... de réir Jian Zhang, N. Arul Murugan, Ye Tian, Chiara Bertagnin, Zengjun Fang, Dongwei Kang, Xiujie Kong, Haiyong Jia, Zhuosen Sun, Ruifang Jia, Ping Gao, Vasanthanathan Poongavanam, Arianna Loregian, Wenfang Xu, Xiuli Ma, Xiao Ding, Bing Huang, Peng Zhan, Xinyong Liu
Foilsithe / Cruthaithe 2018Artigo -
16
Design, Synthesis, and Mechanism Study of Benzenesulfonamide-Containing Phenylalanine Derivatives as Novel HIV-1 Capsid Inhibitors with Improved Antiviral Activities de réir Lin Sun, Alexej Dick, Megan E. Meuser, Tianguang Huang, Waleed A. Zalloum, Chin‐Ho Chen, Srinivasulu Cherukupalli, Shujing Xu, Xiao Ding, Ping Gao, Dongwei Kang, Erik De Clercq, Christophe Pannecouque, Simon Cocklin, Kuo‐Hsiung Lee, Xinyong Liu, Peng Zhan
Foilsithe / Cruthaithe 2020Artigo -
17
Discovery of diarylpyrimidine derivatives bearing piperazine sulfonyl as potent HIV-1 nonnucleoside reverse transcriptase inhibitors de réir Xiangyi Jiang, Boshi Huang, Shawn Rumrill, David Pople, Waleed A. Zalloum, Dongwei Kang, Fabao Zhao, Xiangkai Ji, Zhen Gao, Lide Hu, Zhao Wang, Minghui Xie, Erik De Clercq, Francesc X. Ruiz, Eddy Arnold, Christophe Pannecouque, Xinyong Liu, Peng Zhan
Foilsithe / Cruthaithe 2023Artigo -
18
Identification of Dihydrofuro[3,4-<i>d</i>]pyrimidine Derivatives as Novel HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors with Promising Antiviral Activities and Desirable P... de réir Dongwei Kang, Heng Zhang, Zhao Wang, Tong Zhao, Tiziana Ginex, F. Javier Luque, Yang Yang, Gaochan Wu, Da Feng, Fenju Wei, Jian Zhang, Erik De Clercq, Christophe Pannecouque, Chin Ho Chen, Kuo‐Hsiung Lee, N. Arul Murugan, Thomas A. Steitz, Peng Zhan, Xinyong Liu
Foilsithe / Cruthaithe 2019Artigo -
19
Optimization of N-Substituted Oseltamivir Derivatives as Potent Inhibitors of Group-1 and -2 Influenza A Neuraminidases, Including a Drug-Resistant Variant de réir Jian Zhang, Vasanthanathan Poongavanam, Dongwei Kang, Chiara Bertagnin, Huamei Lu, Xiujie Kong, Han Ju, Xueyi Lu, Ping Gao, Ye Tian, Haiyong Jia, Samuel Desta, Xiao Ding, Lin Sun, Zengjun Fang, Boshi Huang, Xuewu Liang, Ruifang Jia, Xiuli Ma, Wenfang Xu, N. Arul Murugan, Arianna Loregian, Bing Huang, Peng Zhan, Xinyong Liu
Foilsithe / Cruthaithe 2018Artigo -
20
Structural and signaling mechanisms of TAAR1 enabled preferential agonist design de réir Pan Shang, Naikang Rong, Jingjing Jiang, Jie Cheng, Minghui Zhang, Dongwei Kang, Lei S. Qi, Lulu Guo, Yang Gong-ming, Qun Liu, Zhenzhen Zhou, Xiaobing Li, Kongkai Zhu, Qing-Biao Meng, Xiang Han, Wenqi Yan, Yalei Kong, Lejin Yang, Xiaohui Wang, Dapeng Lei, Xin Feng, Xinyong Liu, Xiao Yu, Yue Wang, Qian Li, Zhenhua Shao, Fan Yang, Jin‐Peng Sun
Foilsithe / Cruthaithe 2023Artigo
Uirlisí cuardaigh:
Ábhair a bhaineann le hábhar
Biology
Chemistry
Biochemistry
Pharmacology
Stereochemistry
Gene
Virology
Drug
In vitro
Medicine
Organic chemistry
RNA
Reverse transcriptase
Combinatorial chemistry
Computational biology
Etravirine
Drug discovery
Human immunodeficiency virus (HIV)
Nucleoside
Pathology
Coronavirus disease 2019 (COVID-19)
Disease
Infectious disease (medical specialty)
Nucleoside Reverse Transcriptase Inhibitor
Potency
Pyrimidine
Reverse-transcriptase inhibitor
Antiretroviral therapy
Lead compound
Materials science